Position in ROIV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$35,291,827
-$5,731,041 QoQ
Shares Held
997,226
-32.7% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#69
of 494 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amundi holds $2,427,056,148 across 70 Biotechnology names. ROIV ranks #11 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,546,509 | $768,197,412 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,013,540 | $631,982,729 | |
| 3 | RPRX |
Royalty Pharma plc
|
3,723,864 | $208,797,052 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
617,471 | $185,877,294 | |
| 5 | INCY |
Incyte Corp
|
1,181,498 | $133,934,612 | |
| 6 | TECH |
BIO-TECHNE Corp
|
1,827,241 | $129,094,576 | |
| 7 | MRNA |
Moderna, Inc.
|
888,779 | $62,241,193 | |
| 8 | ARGX |
Argenx SE
|
65,122 | $60,418,237 |
All Filings in ROIV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,291,827 | 997,226 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $41,022,868 | 1,480,970 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $22,643,168 | 1,043,464 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $490,454 | 32,416 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,557,993 | 404,436 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,023,174 | 398,729 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,992,802 | 337,515 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $3,386,943 | 293,496 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,927 | 277 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,440,758 | 231,571 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,846,021 | 164,383 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,201,727 | 359,737 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,386,459 | 236,752 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $187,164 | 25,361 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $183,194 | 22,928 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||